Patents Assigned to Merck Patent GmbH
  • Publication number: 20220162449
    Abstract: The present invention is related to effect pigments exhibiting a deep black body color as well as a blue interference color, to a process for the production of such pigments as well as to the use thereof, especially in coating compositions.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 26, 2022
    Applicant: Merck Patent GmbH
    Inventors: Fumiko SASAKI, Kirsten FRITSCHE, Masayuki MOMOSE, Michael JUNGNITZ
  • Publication number: 20220162504
    Abstract: A polymerisable LC material comprising one or more di- or multireactive mesogenic compounds and one or more compounds of formula UVI, and one or more compounds of formula UVII, Further, a method for its preparation, a polymer film with improved thermal durability and UV stability obtainable from a corresponding polymerisable LC material, a method of preparation of such polymer film, and the use of such polymer film and said polymerisable LC material for optical, electro-optical, decorative or security devices.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 26, 2022
    Applicant: Merck Patent GmbH
    Inventors: Jin-Soon Park, Hoo-Yong Lee, Hyun-Jin Yoon, Heui-Seok Jin
  • Publication number: 20220162505
    Abstract: An optical component and a electro optical devices comprising the optical component. Further, a cholesteric polymerizable liquid crystalline (LC) material, preferably utilized in an optical component in accordance with the present invention, a process for the production of the cholesteric polymerizable LC material, a process to convert the cholesteric polymerizable material into a polymer film, a polymer film obtainable from the cholesteric polymerizable LC material, and the use of the polymer films in an optical component or device comprising a polymer film.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 26, 2022
    Applicant: Merck Patent GmbH
    Inventors: Stephen Mulcahy, Owain Llyr Parri
  • Patent number: 11337978
    Abstract: The present invention is directed to stable lyophilisates comprising 5,10-methylene-(6R)-tetrahydrofolic acid or a pharmaceutically acceptable salt thereof and a dicarboxylic acid, or a salt thereof, as well as, a processes of obtaining the same, and the use of such products.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: May 24, 2022
    Assignee: Merck Patent GmbH
    Inventors: Rudolf Moser, Viola Groehn, Thomas Ammann
  • Publication number: 20220154073
    Abstract: A liquid-crystal (LC) medium comprising polymerizable compounds, its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the PSA (polymer sustained alignment) or SA (self-aligning) mode, an LC display of the PSA or SA mode comprising the LC medium, and a process of manufacturing the LC display.
    Type: Application
    Filed: November 16, 2021
    Publication date: May 19, 2022
    Applicant: Merck Patent GmbH
    Inventors: Eun-Kyu Lee, Jin-Soon Park, Myung-Hee Kim
  • Publication number: 20220153761
    Abstract: ?-Amino boronic acid derivatives are useful for inhibiting the activity of immunoproteasome (LMP7) and for the treatment and/or prevention of medical conditions affected by immunoproteasome activity such as inflammatory and autoimmune diseases, neurodegenerative diseases, proliferative diseases, and cancer.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Applicant: Merck Patent GmbH
    Inventors: Markus Klein, Oliver Schadt, Christina Esder
  • Publication number: 20220144828
    Abstract: Atropisomers, solid forms, salt forms, and deuterated derivatives of the ATM inhibitor 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one as well as compositions thereof are provided.
    Type: Application
    Filed: March 25, 2020
    Publication date: May 12, 2022
    Applicant: Merck Patent GmbH
    Inventors: Thomas Fuchss, Axel Becker, Holger Kubas, Ulrich Graedler
  • Publication number: 20220145180
    Abstract: The invention relates to a polymerisable LC material comprising one or more di- or multireactive mesogenic compounds and one or more compounds of formula UVI, wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film with improved thermal durability and UV stability obtainable from a corresponding polymerisable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerisable LC material for optical, electrooptical, decorative or security devices.
    Type: Application
    Filed: March 16, 2020
    Publication date: May 12, 2022
    Applicant: Merck Patent GmbH
    Inventors: Yong-Hyun CHOI, Hyun-Jin YOON, Bjoern SCHNATWINKEL
  • Publication number: 20220145369
    Abstract: The invention relates generally to the field of detection of biological contaminants on a surface, specifically to a method comprising the steps of providing one or more pieces of sterile and nucleotide-free adhesive fibrous material, affixing said one or more pieces of the fibrous material to said surface, collecting said one or more pieces of the fibrous material from said surface, incubating said one or more pieces of the fibrous material in a solvent, and analyzing the solvent for the presence of biological contaminants. The invention further relates to a kit of parts comprising sterile carriers and instructions to be used for long-term monitoring of microbes.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 12, 2022
    Applicant: MERCK PATENT GMBH
    Inventors: Martin BOBAL, Anna WITTE, Patrick MESTER, Peter ROSSMANITH
  • Patent number: 11326154
    Abstract: The present invention relates to fusion proteins comprising an N-intein polypeptide and an N-intein solubilization partner, and affinity chromatography matrices comprising such fusion proteins, as well as methods of using same.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: May 10, 2022
    Assignee: Merck Patent GmbH
    Inventors: Martin Zillmann, Joe Orlando
  • Patent number: 11326102
    Abstract: The invention relates to a liquid-crystalline medium, preferably having a nematic phase and dielectric anisotropy of 0.5 or more, which comprises one or more compounds of formula YX in which the parameters have the meanings given in the text, to the use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the use of the compounds of formula YX for the improvement of the transmission and/or response times of a liquid-crystalline medium which comprises one or more additional mesogenic compounds.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: May 10, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Atsutaka Manabe, Constanze Brocke, Brigitte Schuler
  • Patent number: 11329233
    Abstract: The invention relates to heterocyclic compounds, particularly for use in electronic devices. The invention further relates to a method for producing the compounds according to the invention, and to electronic devices comprising same.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: May 10, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Philipp Stoessel, Nils Koenen, Philipp Harbach, Dominik Joosten, Amir Parham, Anja Jatsch
  • Patent number: 11329234
    Abstract: An object of the present invention is to provide an organic electroluminescent element containing an organic layer interposed between an anode and a cathode, the organic layer containing at least one light emitting layer, wherein the at least one light emitting layer contains a ?-conjugated compound having an electron donor portion and an electron acceptor portion in the molecule; the ?-conjugated compound has a direction vector from an atom having a HOMO orbital in the electron donor portion to an electron cloud of the HOMO orbital, and a direction vector from an atom having a LUMO orbital in the electron acceptor portion to an electron cloud of the LUMO orbital, and the two direction vectors form an angle ? in the range of 90 to 180 degrees; and the ?-conjugated compound has a plurality of the electron donor portions or a plurality of the electron acceptor portions.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: May 10, 2022
    Assignee: Merck Patent GmbH
    Inventors: Yasuo Miyata, Taketo Namikawa, Hiroshi Kita
  • Publication number: 20220134285
    Abstract: A vacuum filtration head (1) having a receptacle for a support (2) for a membrane filter (3) for microbiological testing of a liquid substance to be drawn from an upstream side of the membrane filter (3) to a downstream side of the membrane filter (3) through the membrane filter (3), or the support (2) for such membrane filter (1), a drain chamber (4) located downstream of the support (2) and communicating with a downstream side of the membrane filter (3) receiving the liquid substance passed through the membrane filter (3), and a drain channel (5) communicating with the drain chamber (4) at an opening (9) and communicating with a vacuum. A protective shield (6) is arranged in the filtration head (1) interfering with a fictive direct line connection while retaining a fluid path (7) to the drain channel (5) past the protective shield (6).
    Type: Application
    Filed: January 14, 2020
    Publication date: May 5, 2022
    Applicant: Merck Patent GmbH
    Inventors: Fabrice COMINI, Didier METZ, Philippe RIVAT
  • Patent number: 11322696
    Abstract: The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes of the formula (1):
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: May 3, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Philipp Stoessel, Nils Koenen, Christian Ehrenreich
  • Publication number: 20220127254
    Abstract: Compounds of the formula I are provided. These compounds can inhibit c-Kit kinase and can be employed for the treatment of cancer.
    Type: Application
    Filed: February 10, 2020
    Publication date: April 28, 2022
    Applicant: Merck Patent GmbH
    Inventors: Dieter DORSCH, Andreas Blum
  • Publication number: 20220128846
    Abstract: A method for controlling the state of two or more liquid crystal-based switchable elements is proposed, wherein the switchable elements are configured as smart windows and/or as switchable subunits of smart windows, wherein in a first step a), at least two keyframes are defined, wherein each keyframe comprises setting values defining the intended state of a group of switchable elements. In a subsequent step b), a display frame is computed, wherein the display frame comprises setting values for the state of the group of switchable elements based on at least one of the defined keyframes. In a subsequent step c), the state of each of the switchable elements of the group of switchable elements is set as defined by the setting values of the computed display frame. Also, a master controller for use with the method, and a system implementing the method.
    Type: Application
    Filed: October 27, 2021
    Publication date: April 28, 2022
    Applicant: Merck Patent GmbH
    Inventors: Ties de Jong, Heiko Christ, Jasper van den Muijsenberg, Jens Osterodt, Bram Riemens
  • Publication number: 20220127286
    Abstract: The present invention relates to a compound suitable as ligand for binding to the surface of a semiconductor nanoparticle, said compound comprising an anchor group, a linker group and an organic functional group; a semiconductor nanoparticle have said ligand attached to the outermost particle surface; a composition, a formulation and a process for the preparation of said semiconductor nanoparticle; and an electronic device.
    Type: Application
    Filed: February 2, 2020
    Publication date: April 28, 2022
    Applicant: MERCK PATENT GMBH
    Inventors: Itai LIEBERMAN, Manuel HAMBURGER, Christian MATUSCHEK, Thomas EBERLE, Beate BURKHART, Sebastian MEYER
  • Publication number: 20220127532
    Abstract: The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment (PS, PSA) and self-aligning (SA) type.
    Type: Application
    Filed: February 14, 2020
    Publication date: April 28, 2022
    Applicant: MERCK PATENT GMBH
    Inventors: Helmut HAENSEL, Qiong TONG, Rocco FORTTE, Edward PLUMMER, Thomas EICHHORN
  • Patent number: 11312909
    Abstract: Polymerizable compounds, to processes and intermediates for the preparation thereof, liquid-crystal (LC) media comprising them, and the use of the polymerizable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type, or a stabilizers in LC media and LC displays.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: April 26, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Qiong Tong, Helga Haas, Alexander Hahn, Kaja Christina Deing, Christoph Marten